Paul Govern Archive — Page 18 of 54

Inga Saknite, PhD, Eric Tkaczyk, MD, PhD, and colleagues are studying how white blood cell motion in the skin’s microvasculature can help predict which stem cell and bone marrow transplant patients would have a relapse of their blood cancer. (photo by Anne Rayner)
March 28, 2022

Study finds 10-second videos predict blood cancer relapse

Vanderbilt research shows that 10-second videos of white blood cell motion in the skin’s microvasculature greatly improved the prediction of which stem cell and bone marrow transplant patients would have a relapse of their blood cancer.

An initiative at VUMC is helping to reduce automated alerts that are often triggered in the electronic health record.
March 24, 2022

VUMC Clickbusters program helps reduce EHR alerts

Vanderbilt’s Clickbusters program is helping to stem alert fatigue associated with the Medical Center’s clinical IT system.

March 17, 2022

U.S. precision medicine research program releases genomic data

The All of Us Research Program released an initial large batch of genomic data on its cloud-based research platform, the Researcher Workbench, including whole genome sequences of 98,600 research participants and genotype data from 165,200 participants.

March 17, 2022

Blood test figures in cancer risk for people with HIV

A Vanderbilt study found that, among adult patients with HIV, those who have lower counts of certain types of blood cells have a markedly higher risk of developing cancer.

March 17, 2022

Talbot named to infection prevention society’s leadership

Vanderbilt’s Tom Talbot, MD, MPH, was recently elected to serve in the leadership of the Society for Healthcare Epidemiology of America.

March 16, 2022

Mangeot named VUMC chief compliance officer

Bob Mangeot has been promoted to Vice President and Chief Compliance Officer at Vanderbilt University Medical Center, having served in the role on an interim basis since December.